PHAT
#2691
Phathom Pharmaceuticals, Inc. - Common Stock
8.9 4 USD
+0.02%
Market Price
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
Range Annuel
Changement quotidien
+1.94%
Changement Mensuel
-25.00%
Evolution sur 6 mois
-26.30%
Changement Annuel
-28.25%
Clôture Précédente
8.7 7
Open
8.9 4
Low
8.9 4
High
8.9 4
Volume
85
Financials
- Market Capitalization 723.25 M
- Employee 371
- Founded 2018
- CEO N/A
- Website www.phathompharma.com
- Headquarter Delaware, United States
- FIGI BBG00P5B2S19
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-5.48
ratio cours/chiffre d'affaires
6.91
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 2674 |  GYRE Gyre Therapeutics, Inc. - Common Stock | 6.68 USD | +0.45% | -5.65% | +13.03% | -19.13% | 744.89 M USD | ||
| 2683 |  BBOT BridgeBio Oncology Therapeutics, Inc. - Common Stock | 9.18 USD | -0.86% | -0.11% | +6.25% | -4.87% | 736.00 M USD | ||
| 2692 |  ALLO Allogene Therapeutics, Inc. - Common Stock | 2.09 USD | +2.45% | -1.42% | +20.11% | +77.12% | 722.08 M USD | ||
| 2699 |  TECX Tectonic Therapeutic, Inc. - Common Stock | 36.70 USD | +2.03% | +0.77% | +23.03% | +113.99% | 717.46 M USD |